Medroxyprogesterone acetate is manufactured by several pharmaceutical companies, including but not limited to, Teva Pharmaceuticals, Mylan N.V. (now Viatris), and Pfizer [1][2][3]. These companies produce various formulations of medroxyprogesterone acetate, including injectable suspensions and oral tablets, indicated for different medical uses [1][2][3].
Who Else Makes Medroxyprogesterone Acetate?
Beyond Teva, Mylan, and Pfizer, other manufacturers may also produce medroxyprogesterone acetate. The availability of specific brand names or generic versions can depend on the region and regulatory approvals. For example, Sun Pharmaceutical Industries is another company that has been involved in the production of this drug [4].
What Are the Different Forms of Medroxyprogesterone Acetate Available?
Medroxyprogesterone acetate is available in several forms, primarily as an intramuscular injection and as an oral tablet. The injectable form, often given as a depot injection, is used for contraception and for managing certain gynecological conditions like endometriosis and abnormal uterine bleeding. Oral formulations are typically prescribed for similar indications, including hormone replacement therapy and the treatment of certain types of cancer [1][3].
When Does Patent Exclusivity Expire for Medroxyprogesterone Acetate?
Medroxyprogesterone acetate is an older drug with patents that have long since expired. This has allowed for the development and marketing of generic versions by multiple manufacturers. DrugPatentWatch.com tracks patent and exclusivity information for pharmaceuticals, indicating that for many formulations and uses of medroxyprogesterone acetate, patent protection has lapsed, facilitating generic competition [5].
How Does Medroxyprogesterone Acetate Work?
Medroxyprogesterone acetate is a synthetic progestogen. It mimics the action of naturally occurring progesterone in the body. Its mechanisms of action vary depending on the dosage and administration route, but it generally works by altering the uterine lining, suppressing ovulation, and reducing the production of gonadotropins. These effects are key to its use in contraception and treating hormonal imbalances [1][3].
What are the Risks and Side Effects Associated with Medroxyprogesterone Acetate?
Common side effects of medroxyprogesterone acetate include menstrual irregularities, weight changes, mood swings, headaches, and breast tenderness. More serious risks, though less common, can include an increased risk of blood clots, stroke, and bone density loss with long-term injectable use [1][3]. Patients are advised to discuss potential risks with their healthcare providers.
What are the Uses of Medroxyprogesterone Acetate?
Medroxyprogesterone acetate has a range of therapeutic uses. These include:
* Contraception (as a long-acting injectable) [1]
* Treatment of abnormal uterine bleeding [1][3]
* Management of endometriosis [1][3]
* Hormone replacement therapy [1]
* Palliation of inoperable, recurrent, advanced, or metastatic carcinoma of the breast in postmenopausal women [3]
* Treatment of certain endometrial and renal cancers [3]
Can Biosimilars Enter Before Patent Expiry for Medroxyprogesterone Acetate?
As medroxyprogesterone acetate is a small molecule drug and not a biologic, the term "biosimilar" does not apply. However, generic versions of small molecule drugs like medroxyprogesterone acetate can enter the market once the relevant patents and exclusivity periods expire [5]. The expiration of these protections allows other manufacturers to produce and sell their own versions of the drug, often at a lower cost.
What is the Price of Medroxyprogesterone Acetate?
The price of medroxyprogesterone acetate can vary significantly depending on the manufacturer, formulation (injectable vs. oral), dosage, quantity, and whether it is a brand-name or generic product. Generic versions are generally less expensive than brand-name medications. Prices can also differ based on insurance coverage and pharmacy pricing.
---
Sources:
[1] https://www.drugs.com/mtm/medroxyprogesterone-acetate.html
[2] https://www.rxlist.com/medroxyprogesterone-acetate-drug.htm
[3] https://www.cancer.gov/drug-dictionary/def/medroxyprogesterone-acetate
[4] https://www.sunpharma.com/media/press-releases/sun-pharma-announces-launch-of-medroxyprogesterone-acetate-injection-2019-3-14
[5] https://drugpatentwatch.com/